Elekta's MOSAIQ and Versa HD earn top honors in 2021 Best in KLAS: Software and Services Report

ATLANTA, February 2, 2021 – Elekta (EKTA-B.ST) today announced that itsMOSAIQ^®Oncology Information System (OIS) and Versa HD™ linear accelerator have been named “Best in KLAS” in the 2021 Best in KLAS: Software and Services Report. MOSAIQ was ranked first in the Oncology (Radiation) category and Versa HD was ranked highest in the Radiation Therapy (equipment) category. Awards are based on evaluations collected byKLAS, an independent research firm.

Recognized as a winner eight times in “Best in KLAS” reports, MOSAIQ is more than an electronic health record. It is the heart ofMOSAIQ Plaza, Elekta’s ecosystem of digital tools that works seamlessly with radiotherapy systems. With MOSAIQ Plaza, healthcare professionals are connected to their patients throughout their comprehensive treatment journey – ensuring efficient, standardized daily practice that delivers pathway-driven, value-based healthcare.

Receiving the highest score for radiation therapy in the report,Versa HD, Elekta’s most advanced and versatile linear accelerator, allows clinicians to perform a wide range of stereotactic treatments, therapy that requires the highest levels of accuracy. These treatments can be delivered in a standard therapy slot of 15 minutes or less.

The accuracy, speed and stereotactic capabilities of Versa HD have given clinicians worldwide new possibilities for personalized, precise radiation therapy for every patient in a way that was not possible before, according to Larry Biscotti, Elekta’s Executive Vice President, Region North and Central America.

“然而,在Covid-19时代,安全的能力ly hypofractionate therapy has made an even bigger impact,” he said. “Delays in radiation therapy – due either to postponed diagnostic screening or centers’ Covid-19 rules that restrict timely radiotherapy delivery – have made it imperative to implement hypofractionation. This technique not only limits the number of patient visits to the health care environment, additionally a hypofractionated course is completed in a shorter time frame, freeing up resources to decrease the backlog of patients awaiting treatment. Versa HD is the right system at the right time.

“In 2020, we were able to demonstrate our adaptability by generating service solutions for our customers operating in a Covid-19 backdrop, offering Radiation Oncology Alternative Payment Model support and education, and capitalizing on our cloud solution to support customers with remote working environments,” Biscotti adds. “MOSAIQ – and other MOSAIQ Plaza digital tools – connect our customers to colleagues, data and patients throughout the entire patient journey.”

This year marks the beginning of Elekta’s third decade of delivering the company’s industry-leading software innovations to customers – the 2021 “Best in KLAS” honors reflecting Elekta’s continuous innovation in oncology informatics.

Elekta will receive the awards on February 23 during the “Best in KLAS Awards Show”.

# # #

For further information, please contact:
Mattias Thorsson, Vice President, Corporate Communications
Tel: +46 70 865 8012, e-mail:Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time

Raven Canzeri, Global Director, Media Relations
Tel: +1 770 670 2524, e-mail:Raven.Canzeri@elekta.com
Time zone: ET: Eastern Time

About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visitelekta.comor follow @Elekta on Twitter.

About KLAS
KLAS is a data-driven company on a mission to improve the world's healthcare by enabling provider and payer voices to be heard and counted. Working with thousands of healthcare professionals, KLAS collects insights on software, services and medical equipment to deliver reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly reflects the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit KLASresearch.com.